Drugs / MVA-NP+M1
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03300362 | Oct 2017 → Oct 2018 | influenza | Barinthus Biotherapeutics | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MVA-NP+M1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03300362 ↗ |
| Modality | Vaccine | “a new vaccine MVA-NP+M1” NCT03300362 ↗ |